Quanli Gao - Search Results

Year	Number of Results
2005	1
2007	1
2009	2
2011	1
2013	1
2014	1
2015	4
2016	6
2017	7
2018	12
2019	10
2020	10
2021	14
2022	19
2023	8
2024	1

1

Pretreatment CD8+PD-1+ to CD4+PD-1+ ratio is associated with the prognosis of advanced melanoma patients treated with PD-1 inhibitors.

Gao Y, Wang Y, Luo Y, Zhang Y, Wang S, Tang X, Qin P, Xu B, Gao Q, Li T. Gao Y, et al. Among authors: gao q. Melanoma Res. 2024 Apr 22. doi: 10.1097/CMR.0000000000000972. Online ahead of print. Melanoma Res. 2024. PMID: 38647119

2

The role of intestinal flora on tumorigenesis, progression, and the efficacy of PD-1/PD-L1 antibodies in colorectal cancer.

Wang S, Xu B, Zhang Y, Chen G, Zhao P, Gao Q, Yuan L. Wang S, et al. Among authors: gao q. Cancer Biol Med. 2023 Dec 23;21(1):65-82. doi: 10.20892/j.issn.2095-3941.2023.0376. Cancer Biol Med. 2023. PMID: 38148328 Free PMC article. Review.

3

The inter-link of ageing, cancer and immunity: findings from real-world retrospective study.

Fu X, Qin P, Li F, Zhu H, You H, Zhang Y, Xu B, Li T, Zhang F, Han L, Zhao L, Ma B, Wang Z, Gao Q. Fu X, et al. Among authors: gao q. Immun Ageing. 2023 Dec 15;20(1):75. doi: 10.1186/s12979-023-00399-9. Immun Ageing. 2023. PMID: 38102684 Free PMC article.

4

Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations.

Wang J, Zhang B, Peng L, Liu X, Sun J, Su C, Wang H, Zhao Z, Si L, Duan J, Zhang H, Li M, Zhu B, Zhang L, Li J, Guo J, Luo R, Qiu W, Ye D, Chu Q, Cui J, Dong X, Fan Y, Gao Q, Guo Y, He Z, Li W, Lin G, Liu L, Liu Y, Qin H, Ren S, Ren X, Wang Y, Xue J, Yang Y, Yang Z, Yue L, Zhan X, Zhang J, Ma J, Qin S, Wang B. Wang J, et al. Among authors: gao q. Ther Adv Med Oncol. 2023 Jul 16;15:17588359231187205. doi: 10.1177/17588359231187205. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37484525 Free PMC article. Review.

5

Repurposing pentamidine for cancer immunotherapy by targeting the PD1/PD-L1 immune checkpoint.

Gu T, Tian X, Wang Y, Yang W, Li W, Song M, Zhao R, Wang M, Gao Q, Li T, Zhang C, Kundu JK, Liu K, Dong Z, Lee MH. Gu T, et al. Among authors: gao q. Front Immunol. 2023 May 2;14:1145028. doi: 10.3389/fimmu.2023.1145028. eCollection 2023. Front Immunol. 2023. PMID: 37205112 Free PMC article.

6

In vivo growth of subclones derived from Lewis lung carcinoma is determined by the tumor microenvironment.

Xu BL, Wang XM, Chen GY, Yuan P, Han L, Qin P, Li TP, You HQ, Zhang CJ, Fu XM, Yuan L, Wang ZB, Gao QL. Xu BL, et al. Am J Cancer Res. 2022 Nov 15;12(11):5255-5270. eCollection 2022. Am J Cancer Res. 2022. PMID: 36504888 Free PMC article.

7

TIGIT-expressing zoledronate-specific γδ T cells display enhanced antitumor activity.

You H, Zhu H, Zhao Y, Guo J, Gao Q. You H, et al. Among authors: gao q. J Leukoc Biol. 2022 Dec;112(6):1691-1700. doi: 10.1002/JLB.5MA0822-759R. Epub 2022 Nov 10. J Leukoc Biol. 2022. PMID: 36353851

8

Intrapleural infusion of tumor cell-derived microparticles packaging methotrexate or saline combined with pemetrexed-cisplatin chemotherapy for the treatment of malignant pleural effusion in advanced non-squamous non-small cell lung cancer: A double-blind, randomized, placebo-controlled study.

Dong X, Huang Y, Yi T, Hu C, Gao Q, Chen Y, Zhang J, Chen J, Liu L, Meng R, Zhang S, Dai X, Fei S, Jin Y, Yin P, Hu Y, Wu G. Dong X, et al. Among authors: gao q. Front Immunol. 2022 Oct 5;13:1002938. doi: 10.3389/fimmu.2022.1002938. eCollection 2022. Front Immunol. 2022. PMID: 36275698 Free PMC article. Clinical Trial.

9

Case Report: Successful engraftment of allogeneic hematopoietic stem cells using CAR-T cell therapy as the conditioning regimen in R/R Ph⁺ B cell acute lymphoblastic leukemia.

Han L, Zhao R, Yang J, Zu Y, Liu Y, Zhou J, Li L, Huang Z, Zhang J, Gao Q, Song Y, Zhou K. Han L, et al. Among authors: gao q. Front Immunol. 2022 Sep 26;13:965932. doi: 10.3389/fimmu.2022.965932. eCollection 2022. Front Immunol. 2022. PMID: 36225940 Free PMC article.

10

Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer.

Ma B, Zhou Y, Shang Y, Zhang Y, Xu B, Fu X, Guo J, Yang Y, Zhang F, Zhou M, Huang H, Li F, Lin H, Zhao L, Wang Z, Gao Q. Ma B, et al. Among authors: gao q. Front Oncol. 2022 Sep 9;12:852885. doi: 10.3389/fonc.2022.852885. eCollection 2022. Front Oncol. 2022. PMID: 36158690 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year